The outcomes supply solely a snapshot of remdesivir’s effectiveness. The identical trials are being run concurrently at different establishments, and it’s inconceivable to decide the complete research outcomes with any certainty. Nonetheless, no different medical data from the Gilead research have been launched to date, and pleasure is excessive. Final month, President Trump touted the potential for remdesivir — as he has for a lot of still-unproven treatments — and stated it “seems to have a very good result.”

In an announcement Thursday, Gilead stated: “What we can say at this stage is that we look forward to data from ongoing studies becoming available.”